Georgetown University Medical Center

Anthony Letai discusses how understanding programmed cell death can guide the selection of cancer treatments. The seminar explains how apoptotic signalling can be measured and how these measurements can identify drugs capable of killing cancer cells. Hybrid: New Research Building Auditorium, Georgetown University Medical Center, Washington, DC, and Zoom. Monday 5 October 2026, 16:30–17:30 EDT (America/New_York; UTC−4). Use the attendance registration form or the event’s Zoom link on the organizer page. Organized by Georgetown’s Distinguished Scientist Seminar Series. Letai is Director of the National Cancer Institute. An in-person reception follows the seminar.

Farhad Danesh examines how mitochondrial reactive oxygen species, altered metabolism and structural remodelling convert hyperglycaemia into progressive kidney injury. The seminar connects mitochondrial dynamics with diabetic microvascular damage, non-coding RNA regulation and experimental models that establish causal links to disease progression. Genome-wide CRISPR screens and spatial metabolomics reveal cellular gene-regulatory and metabolic changes. Integrating these approaches with molecular genetics, genomics and epigenomics, the work seeks therapeutic targets to prevent diabetic kidney disease progressing to kidney failure. Hybrid: New Research Building Auditorium, Georgetown University Medical Center, Washington, DC, and Zoom. Thursday 24 September 2026, 16:00–17:00 EDT (America/New_York; UTC−4). Use the public event registration form to arrange attendance, or follow its Zoom link for remote participation. Organized by Georgetown’s Distinguished Scientist Seminar Series. Danesh is Professor of Medicine and Chief of Nephrology at MD Anderson.